Delphia (USA) Inc. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Delphia (USA) Inc. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$67,651
-58.0%
10,587
-36.9%
0.08%
-57.6%
Q3 2022$161,000
-41.9%
16,791
-33.0%
0.18%
-3.7%
Q2 2022$277,000
-2.5%
25,060
+46.9%
0.19%
-10.3%
Q1 2022$284,00017,0600.21%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders